GSK Seeks To Forgo Trial In First Zofran MDL Bellwether
GlaxoSmithKline argued in court Wednesday to prevail on simply a paper record in the first trial in a multidistrict case over whether the company's anti-nausea medication Zofran caused birth defects, claiming...To view the full article, register now.
Already a subscriber? Click here to view full article